Similar articles

• Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.

  Mangini RJ. Mangini RJ. Am J Hosp Pharm. 1979 Apr;36(4):497-504. Am J Hosp Pharm. 1979. PMID: 433935 No abstract available.
• Hyperuricemia and gout. Classification, complications and management.

  Boss GR, Seegmiller JE. Boss GR, et al. N Engl J Med. 1979 Jun 28;300(26):1459-68. doi: 10.1056/NEJM197906283002604. N Engl J Med. 1979. PMID: 221806 Review. No abstract available.
• [Hyperuricemia and gout--treatment].

  Gröbner W, Walter-Sack I. Gröbner W, et al. Dtsch Med Wochenschr. 2002 Feb 1;127(5):210-3. doi: 10.1055/s-2002-19907. Dtsch Med Wochenschr. 2002. PMID: 11821994 German. No abstract available.
• [Hyperuricemia due to hypoxanthine-guanine-phosphoribosyltransferase deficiency].

  Blétry O, Cartier P, Hamet M, Clauvel JP. Blétry O, et al. Nouv Presse Med. 1974 Apr 20;3(16):995-9. Nouv Presse Med. 1974. PMID: 4836472 French. No abstract available.
• [Hyperuricemia, gout and gout-induced nephropathy].

  Arkhipov VE, Borisov IA, Nasonov EL, Sura VV. Arkhipov VE, et al. Ter Arkh. 1980;52(4):133-42. Ter Arkh. 1980. PMID: 6996182 Review. Russian. No abstract available.